Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2
Open Access
- 23 April 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Tuberculosis
- Vol. 2, 1378068
Abstract
The COVID pandemic and tuberculosis (TB) endemicity is double trouble to much of the world. SARS-CoV-2 and Mycobacterium tuberculosis (Mtb), causative agents of COVID and TB, respectively, are both infectious respiratory pathogens involving close communities and individuals. Both pathogens can cause lung disease, involving unbalanced inflammatory cell immune responses that can lead to a syndemic impact. Moreover, dual infection is common in certain settings. In low- and middle- income countries, most individuals with SARS-CoV-2 infection or COVID-19, in fact, will have been exposed to or infected with Mtb and some will develop active TB. Here we review the literature examining the diverse interactions of M. tuberculosis infection and of BCG vaccination with SARS-CoV-2. We discuss areas in which contradictory results have been published and conclude that there are still several unresolved issues that warrant further study on the co-pathogenesis of SARS-CoV-2 and Mtb and BCG- mediated heterologous protection against COVID-19.Keywords
This publication has 101 references indexed in Scilit:
- Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control TrialInfectious Diseases and Therapy, 2022
- Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020JAMA Network Open, 2021
- Is the course of COVID‐19 associated with tuberculin skin test diameter? A retrospective studyJournal of Medical Virology, 2021
- Coronavirus Activates an Altruistic Stem Cell–Mediated Defense Mechanism that Reactivates Dormant TuberculosisThe American Journal of Pathology, 2021
- An updated meta‐analysis on the association between tuberculosis and COVID‐19 severity and mortalityJournal of Medical Virology, 2021
- Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergyInfection, 2021
- Clinical, Biological and Molecular Aspects of COVID-192021
- Impact of COVID‐19 in patients with concurrent co‐infections: A systematic review and meta‐analysesJournal of Medical Virology, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against TuberculosisCell, 2018